The medical black technology system of the top student

It's eight o'clock in the morning.

Wang Ting came to her office. After putting down her backpack, Wang Ting turned on her computer and started working.

As a news media person, the first thing Wang Ting does every day at work is to open the website and read international news to see if there are any big news in the world.

Today, Wang Ting opened the news website as usual.

However, when she saw the first news on the website, Wang Ting was stunned for a moment.

It was an extremely eye-catching headline: Pfizer has developed a targeted drug to treat pancreatic cancer. 》

When she saw this report, Wang Ting's eyes widened immediately, and she quickly scrolled down the report.

Today at 8 o'clock New York time, Pfizer held a press conference and announced that it has developed a targeted drug for the treatment of pancreatic cancer.

Of all cancers, pancreatic cancer continues to be one of the most difficult.

Mr. Jobs, the former CEO of Apple, Mr. Pavarotti, the famous singer, and Professor Steinman, the former Nobel Prize winner. Too many people have died of pancreatic cancer.

For the medical community, pancreatic cancer is like an indelible curse.

But today, Pfizer has broken this curse. Currently, Pfizer's drug has passed phase three clinical trials and will be officially launched soon.

After seeing this news, Wang Ting's face suddenly showed joy.

This is big news!

You know, there are really not many drugs currently used to treat pancreatic cancer.

And most of the time, these drugs are difficult to produce good therapeutic effects.

But now, if Pfizer's drug can be launched on the market, it will definitely bring treatment hope to many pancreatic cancer patients and save the lives of many pancreatic cancer patients.

Thinking of this, Wang Ting quickly contacted the reporter who published this report.

After obtaining the consent of the other reporter, Wang Ting quickly reprinted the report and posted it on a domestic website.

And Wang Ting is not the only one who has done this. There are many people outside the news media who have seen this report.

After many domestic media discovered this report, they immediately began to reprint it domestically.

As various media reprinted it, the news that Pfizer had developed a targeted drug for pancreatic cancer soon spread on major media and social platforms.

Early in the morning, Lu Liang left the dormitory as usual.

As the time approaches New Year's Day, the weather is getting colder and colder.

The school cafeteria is also much deserted. After classes are over, most students choose to stay in their dormitories and not come out.

Lu Liang bought two buns in the cafeteria and put them in his pocket to warm his hands.

After walking out of the cafeteria, the cold wind howled, like cold ice knives scraping against my face.

Lu Liang tightened his collar and walked towards the study room in the teaching building.

After walking into the study room and feeling the warm air coming from the air conditioner, Lu Liang took off his hat.

Then he let out a long breath, as if he wanted to spit out all the coldness in his body.

In the study room, Wang Wentao had already arrived. He packed a bowl of noodles from somewhere and was slurping noodles hard on his seat.

After seeing Lu Liang, Wang Wentao raised his head and said hello: You came so early.

Not as early as you.

Lu Liang breathed a sigh of relief and replied, It's so cold today.

Wang Wentao said with interest at this time: Brother, have you read the news?

I didn't see it. Is there anything big going on? Lu Liang asked without interest.

Wang Wentao said: It's news from Pfizer. It is said that Pfizer has successfully developed a targeted drug for the treatment of pancreatic cancer, and it has passed the third phase of clinical trials.

It is said that the ORR of clinical results can reach 50%.

This result can be said to be very excellent.

You know, so far, the five-year survival rate for pancreatic cancer patients is less than 5%.

After this drug is used clinically, the five-year survival rate of pancreatic cancer patients will be greatly improved.

However, Lu Liang was somewhat surprised when he heard the news.

Isn't this a coincidence?

The Pin1 he is focusing on now happens to be a target of pancreatic cancer.

Lu Liang took out his mobile phone and browsed the Internet, wanting to see specific information about Pfizer's targeted drug for the treatment of pancreatic cancer.

After entering keywords to search, Lu Liang quickly found the report.

That was a report by a reporter from the New York Times. It has been reproduced by many domestic media and can be found with a casual search.

However, after browsing the report, Lu Liang did not see much information about drugs.

Afterwards, Lu Liang flipped through the comments on the report.

Most of the people who commented in the comment area were pancreatic cancer patients. For those pancreatic cancer patients, this is undoubtedly exciting news.

Great, as long as this drug is available in China, my mother's disease will be cured!

Finally, one day, there will be corresponding targeted drugs for pancreatic cancer. Finally, we no longer need to rely on chemotherapy drugs every day!

When this drug is released, how many pancreatic cancer patients will be cured!

Of course, in addition to the patients, some public figures also rushed over to join in the fun, and they would not miss any opportunity to express their opinions.

The development of pharmaceuticals really depends on those foreign pharmaceutical giants. Domestic technology is still far behind. It is simply unthinkable to put this kind of medicine in China.

Why are Western pharmaceutical companies always able to develop such breakthrough drugs? Where do we fall behind? Let's reflect!.

Lu Liang didn't pay much attention to these comments. His eyes quickly skipped over these comments.

After reading all the comments, Lu Liang still could not find specific information about Pfizer's drug.

This made Lu Liang a little regretful.

He was actually quite interested in this drug from Pfizer, and originally wanted to understand the mechanism of this drug.

But now he couldn't even find what the medicine was called, so he had no choice but to give up.

After putting the phone away, Wang Wentao on the side seemed to remember something, and he asked: By the way, senior brother, you are conducting experiments now. Isn't it also related to pancreatic cancer? What are the results of that batch of experiments? Already?

The test Wang Wentao mentioned naturally refers to the data results of Lu Liang's batch of Pin1 knockout mouse tests.

Some time ago, Lu Liang's batch of tests had reached the end date. After collecting the samples, only the testing of sample data remained.

Lu Liang thought for a moment and replied: There are still a few sample indicators that have not been tested. Once the testing is completed, we will almost know.